4-amino-n-ethyl-n-(beta-hydroxy-ethyl)-m-toluidine has been researched along with Dermatitis, Atopic in 1 studies
*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goh, CL; Kwok, SF; Rajan, VS | 1 |
1 other study(ies) available for 4-amino-n-ethyl-n-(beta-hydroxy-ethyl)-m-toluidine and Dermatitis, Atopic
| Article | Year |
|---|---|
Cross sensitivity in colour developers.
Topics: Adult; Chemical Phenomena; Chemistry; Dermatitis, Atopic; Dermatitis, Contact; Humans; Lichen Planus; Occupational Diseases; Phenylenediamines; Photography; Sulfonamides; Toluene | 1984 |